Expertise in
1
conditions

Katarina Uttervall

Stockholm, AB, SE 
Expertise in
1
conditions
Stockholm, AB, SE 

Overview

Katarina Uttervall practices practicing medicine in Stockholm, Sweden.

Ms. Uttervall is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Multiple Myeloma, Plasmacytoma, and Smoldering Multiple Myeloma.

She is actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Stockholm, AB, Sweden
Other Locations
Huddinge, AB, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase I/II, Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Anti-Cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM 5
A Phase I/II, Randomized, Open-label Platform Study Utilizing a Master Protocol to Study Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Anti-Cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) - DREAMM 5
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, GSK3174998, Feladilimab, Nirogacestat, Dostarlimab, Isatuximab
Study Phase: Phase 1/Phase 2

19 Total Publications

REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials.
REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials.
Journal: Haematologica
Published: September 30, 2025

Frequently Asked Questions about Katarina Uttervall

Is Katarina Uttervall a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Katarina Uttervall is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Katarina Uttervall participate in research or clinical trials?

Yes. Katarina Uttervall has published 19 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Katarina Uttervall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Uttervall's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile